A5360 (MINMON): A Single-Arm Study To Evaluate The Feasibility And Efficacy Of A Minimal Monitoring Strategy To Deliver Pan-Genotypic Ribavirin-Free HCV Therapy To Populations Living With HCV Who Are HCV Treatment Naïve With Evidence Of Active HCV Infection